Mental Health & Depression: 67 new trials, 3,258 recruiting, 1,734 papers published, June 22–29, 3628 off-label use reports.
Doctiplus - We are allways here!
Doctiplus - We are allways here!
Mental Health & Depression: 67 new trials, 3,258 recruiting, 1,734 papers published, June 22–29, 3628 off-label use reports.
Cancer & Oncology: 197 new trials, 18,955 recruiting, 4 Phase 3. Off Label Use tops 8596 reports. June 22–29.
Diabetes: 52 new trials, 1,956 recruiting, 11 Phase 3. Off-label use tops adverse reports at 10,229. June 22–29.
Heart Disease & Cardiovascular: 109 new trials, 8,815 recruiting, 2,323 papers published June 22–29, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 10 new trials, 955 recruiting, 1,386 papers published, June 22–29, 628 death reports.
Mental Health & Depression: 66 new trials, 3,254 recruiting, 1,793 papers published, June 15–22, 3628 off-label use reports.
Cancer & Oncology: 184 new trials, 18,885 recruiting, 5 Phase 3 trials. Off Label Use tops 8,596 reports. June 15–22.
Diabetes: 25 new trials, 1,950 recruiting, 1,472 papers published. Off-label use tops adverse reports at 10,229. June 15–22.
Heart Disease & Cardiovascular: 104 new trials, 8,766 recruiting, 2,369 papers published June 15–22, Fatigue tops adverse reports at 6,625.
Dementia & Alzheimer’s: 10 new trials, 949 recruiting, 1,406 papers published, June 15–22, 628 death reports.